Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study

被引:97
作者
Wikstrom, I. [1 ]
Lindell, M. [2 ]
Sanner, K. [1 ]
Wilander, E. [2 ]
机构
[1] Uppsala Univ, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden
[2] Uppsala Univ, Dept Genet & Pathol, S-75185 Uppsala, Sweden
关键词
cervix; human papilloma virus; self-sampling; cytological screening; HIGH-RISK HPV; CERVICAL-CANCER; VAGINAL SMEAR; ATTENDANCE;
D O I
10.1038/bjc.2011.236
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Most women with cervical cancer have not participated in Pap-smear screening. Self-sampling of vaginal fluid in combination with high-risk HPV testing may be a method to increase the attendance rate. METHODS: A total of 4060 women, 39-60 years old, who had not attended the organised Pap-smear screening for 6 years or more were randomised into two equal groups. A study group was offered to self-sample vaginal fluid (Qvintip) at home and/or recommended to attend the Pap-smear screening. The collected fluid after self-sampling was examined for the presence of high-risk HPV (Hybrid Capture 2 method). Controls were only recommended to attend the Pap-smear screening. The end point was a histological identification of CIN2-3. RESULTS: The participation rate was 39% (771 out of 2000) in the self-sampling group and 9% (188 out of 2060) in the conventional cytology (P < 0.001). The number of histological CIN2-3 alterations detected was 0.4% (8 out of 2000) among women offered self-sampling of vaginal fluid and 0.07% (3 out of 4060) in women offered Pap-smears. The odds ratio (OR) for offering self-sampling and HPV testing instead of Pap-smear screening for detection of CIN2-3 was OR 5.42 (95% CI: 1.30-31.8). CONCLUSION: Offering self-sampling of vaginal fluid followed by a high-risk HPV test was considerably more effective for detection of histological CIN2-3 lesions in comparison with offering Pap-test in a midwife reception in women not regularly attending organised screening. British Journal of Cancer (2011) 105, 337-339. doi:10.1038/bjc.2011.236 www.bjcancer.com Published online 5 July 2011 (C) 2011 Cancer Research UK
引用
收藏
页码:337 / 339
页数:3
相关论文
共 15 条
  • [1] Screening-preventable cervical cancer risks:: Evidence from a nationwide audit in Sweden
    Andrae, Bengt
    Kemetli, Levent
    Sparen, Par
    Silfverdal, Lena
    Strander, Bjorn
    Ryd, Walter
    Dillner, Joakim
    Tornberg, Sven
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09): : 622 - 629
  • [2] Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands
    Bos, Anita B.
    Rebolj, Matejka
    Habbema, J. Dik F.
    van Ballegooijen, Marjolein
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (10) : 2372 - 2375
  • [3] Eaker S, 2004, CANCER EPIDEM BIOMAR, V13, P346
  • [4] HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
    Gok, Murat
    Heideman, Danielle A. M.
    van Kemenade, Folkert J.
    Berkhof, Johannes
    Rozendaal, Lawrence
    Spruyt, Johan W. M.
    Voorhorst, Feja
    Belien, Jeroen A. M.
    Babovic, Milena
    Snijders, Peter J. F.
    Meijer, Chris J. L. M.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 : 905
  • [5] Low efficiency of cytologic screening for cancer in situ of the cervix in older women
    Gustafsson, L
    Sparen, P
    Gustafsson, M
    Pettersson, B
    Wilander, E
    Bergstrom, R
    Adami, HO
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (06) : 804 - 809
  • [6] HPV test shows low sensitivity of Pap screen in older women
    Gyllensten, Ulf
    Lindell, Monica
    Gustafsson, Inger
    Wilander, Erik
    [J]. LANCET ONCOLOGY, 2010, 11 (06) : 509 - 510
  • [7] Screening history of women in Malmo with invasive cervical cancer
    Lindqvist, Pelle G.
    Hellsten, Charlotte
    Rippe, Amanda
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 137 (01): : 77 - 83
  • [8] Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    Castle, Philip E.
    Hesselink, Albertus T.
    Franco, Eduardo L.
    Ronco, Guglielmo
    Arbyn, Marc
    Bosch, F. Xavier
    Cuzick, Jack
    Dillner, Joakim
    Heideman, Danielle A. M.
    Snijders, Peter J. F.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) : 516 - 520
  • [9] Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden
    Oscarsson, Marie G.
    Benzein, Eva G.
    Wijma, Barbro E.
    [J]. JOURNAL OF PSYCHOSOMATIC OBSTETRICS & GYNECOLOGY, 2008, 29 (01) : 23 - 31
  • [10] Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
    Ronco, Guglielmo
    Giorgi-Rossi, Paolo
    Carozzi, Francesca
    Confortini, Massimo
    Dalla Palma, Paolo
    Del Mistro, Annarosa
    Ghiringhello, Bruno
    Girlando, Salvatore
    Gillio-Tos, Anna
    De Marco, Laura
    Naldoni, Carlo
    Pierotti, Paola
    Rizzolo, Raffaella
    Schincaglia, Patrizia
    Zorzi, Manuel
    Zappa, Marco
    Segnan, Nereo
    Cuzick, Jack
    [J]. LANCET ONCOLOGY, 2010, 11 (03) : 249 - 257